IP Library Granted Patent US 9,242,992
Granted Patent B2
US 9,242,992 · App. 13/318,230 · Granted Jan 26, 2016

Crystal form of tricyclic benzopyran compound and production method thereof

Inventors: Yasutaka Takada (Funabashi, JP); Miyako Kamon (Funabashi, JP); Shiro Kawahara (Funabashi, JP); Yasuhiro Umeda (Funabashi, JP)
Assignee: NISSAN CHEMICAL INDUSTRIES, LTD.
C07D491/052
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,242,992
App. No.
13/318,230
Granted
Jan 26, 2016
Kind
B2
Abstract

Crystal forms of (3R,4S)-7-hydroxymethyl-2,2,9-trimethyl-4-(phenethylamino)-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol that are excellent as a drug, and production methods thereof. Production methods include crystallizing (3R,4S)-7-hydroxymethyl-2,2,9-trimethyl-4-(phenethylamino)-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol from an acetate ester solvent, an aliphatic hydrocarbon solvent, a nitrile solvent, an aromatic hydrocarbon solvent, a ketone solvent or an ether solvent, and crystal forms obtained according to the methods.

Claims (32)

1. A crystal form of (3R,4S)-7-hydroxymethyl-2,2,9-trimethyl-4-(phenethylamino)-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol of Formula (1):

wherein the crystal form is selected from the group consisting of:

an A-form having characteristic peaks at diffraction angles (2θ) of 5.6, 8.2, 12.0, 14.7, 16.6, 16.9, 17.9, 18.4, 22.5, 24.5, and 27.6 in a powder X-ray diffractogram of the crystal;

a B-form having characteristic peaks at diffraction angles (2θ) of 6.4, 8.7, 12.8, 17.5, 19.1, 20.7, 22.0, 24.8, and 26.6 in a powder X-ray diffractogram of the crystal;

a E-form having characteristic peaks at diffraction angles (2θ) of 9.1, 12.8, 13.1, 14.6, 15.2, 16.4, 22.1, 23.6, and 24.8 in a powder X-ray diffractogram of the crystal;

a F-form having characteristic peaks at diffraction angles (2θ) of 6.8, 11.7, 13.7, 16.8, 18.0, 19.3, 20.4, 20.8, 24.6, and 25.6 in a powder X-ray diffractogram of the crystal;

a G-form having characteristic peaks at diffraction angles (2θ) of 6.7, 11.6, 11.9, 13.6, 16.6, 17.7, 18.6, 19.1, 19.8, 20.1, and 20.8 in a powder X-ray diffractogram of the crystal; and

a H-form having characteristic peaks at diffraction angles (2θ) of 6.0, 16.4, 17.0, 19.2, 19.8, 20.3, 21.0, and 22.8 in a powder X-ray diffractogram of the crystal.

2. The crystal of claim 1 , wherein the crystal is in the A-form having characteristic peaks at diffraction angles (2θ) of 5.6, 8.2, 12.0, 14.7, 16.6, 16.9, 17.9, 18.4, 22.5, 24.5, and 27.6 in a powder X-ray diffractogram of the crystal.

3. The crystal of claim 1 , wherein the crystal is in the B-form having characteristic peaks at diffraction angles (2θ) of 6.4, 8.7, 12.8, 17.5, 19.1, 20.7, 22.0, 24.8, and 26.6 in a powder X-ray diffractogram of the crystal.

4. The crystal of claim 1 , wherein the crystal is in the E-form having characteristic peaks at diffraction angles (2θ) of 9.1, 12.8, 13.1, 14.6, 15.2, 16.4, 22.1, 23.6, and 24.8 in a powder X-ray diffractogram of the crystal.

5. The crystal of claim 1 , wherein the crystal is in the F-form having characteristic peaks at diffraction angles (2θ) of 6.8, 11.7, 13.7, 16.8, 18.0, 19.3, 20.4, 20.8, 24.6, and 25.6 in a powder X-ray diffractogram of the crystal.

6. The crystal of claim 1 , wherein the crystal is in the G-form having characteristic peaks at diffraction angles (2θ) of 6.7, 11.6, 11.9, 13.6, 16.6, 17.7, 18.6, 19.1, 19.8, 20.1, and 20.8 in a powder X-ray diffractogram of the crystal.

7. The crystal of claim 1 , wherein the crystal is in the H-form having characteristic peaks at diffraction angles (2θ) of 6.0, 16.4, 17.0, 19.2, 19.8, 20.3, 21.0, and 22.8 in a powder X-ray diffractogram of the crystal.

8. A production method of the crystal of claim 2 , comprising crystallizing the compound of Formula (1) in an ester solvent.

9. A production method of the crystal of claim 2 , comprising crystallizing the compound of Formula (1) in an aliphatic hydrocarbon solvent.

10. A production method of the crystal of claim 2 , comprising crystallizing the compound of Formula (1) in a nitrile solvent.

11. A production method of the crystal of claim 2 , comprising crystallizing the compound of Formula (1) in an aromatic hydrocarbon solvent.

12. A production method of the crystal of claim 2 , comprising crystallizing the compound of Formula (1) in a ketone solvent.

13. A production method of the crystal of claim 3 , comprising crystallizing the compound of Formula (1) from a water-containing organic solvent.

14. A production method of the crystal of claim 4 , comprising:

heating and dissolving the compound of Formula (1) in an acetate ester solvent or a ketone solvent; and

performing one shot addition of an aliphatic hydrocarbon solvent and crash cooling.

15. A production method of the crystal of claim 5 , comprising crystallizing the compound of Formula (1) from ethanol.

16. A production method of the crystal of claim 6 , comprising crystallizing the compound of Formula (1) from 2-propanol.

17. A production method of the crystal of claim 7 , comprising:

heating and dissolving the compound of Formula (1) in an ether solvent; and

performing one shot addition of cyclohexane and crash cooling.

18. A production method of the crystal of claim 2 , characterized in that the compound of Formula (1) is dissolved in an ester solvent followed by adding an aliphatic hydrocarbon solvent to be crystallized.

19. A production method of the crystal of claim 18 , characterized in that the compound of Formula (1) is dissolved in ethyl acetate solvent followed by adding heptane to be crystallized.

20. A production method of the crystal of claim 19 , characterized by cooling down 0-5° C. after adding heptane.

21. A production method of the crystal of claim 14 , wherein the acetate ester solvent or the ketone solvent is ethyl acetate and the aliphatic hydrocarbon solvent is heptane.

Assignments (2)
CHANGE OF NAME AND ADDRESS Recorded Oct 19, 2018
From: NISSAN CHEMICAL INDUSTREIS, LTD.
To: NISSAN CHEMICAL CORPORATION
Reel/Frame 047271/0151 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2011
From: TAKADA, YASUTAKA; KAMON, MIYAKO; KAWAHARA, SHIRO; UMEDA, YASUHIRO
To: NISSAN CHEMICAL INDUSTRIES, LTD.
Reel/Frame 027256/0112 →
Priority Claims (1)
JP 2009-111281 · Apr 30, 2009 · national
Continuity (1)
Related Publication 20120059169A1 · Mar 8, 2012